AdaptHealth Corp. (AHCO)
AHCO trades on Nasdaq in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1725255/000162828026011213/0001628280-26-011213-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | AHCO on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001725255 |
| SEC industry code | Services-Home Health Care Services |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $3.2B |
| Net income | -$70.8M |
| Operating income | $90.9M |
| Net margin | -2.2% |
| Operating margin | 2.8% |
| Revenue growth | -0.5% |
| Cash | $106.1M |
| Total assets | $4.3B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.3× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-03 |
| Cash and burn | $48.0M cash; operating cash flow $144.7M a quarter. | Report 2026-09-30 |
| Shares outstanding | 136,525,348 (2026-10-30); 135,424,334 a year earlier; 136,389,655 three years earlier. | Cover page 2026-10-30 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | KPMG LLP, Philadelphia, Pennsylvania, United States | PCAOB Form AP 2026-03-24 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $25.0M, sold $278K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $745.6M | -$154.0M | $156.6M | Not filed | $1.9B | $3.6B | 10-Q 2026-11-03 |
| Q2 2026 2026-06-30 | $740.3M | -$133.9M | $145.3M | Not filed | $1.9B | $3.5B | 10-Q 2026-08-04 |
| Q1 2026 2026-03-31 | $819.8M | -$16.0M | $93.7M | $48.0M | $1.8B | $3.4B | 10-Q 2026-05-05 |
| Q4 2025 2025-12-31 | $1.3B | -$102.8M | $183.2M | $106.1M | $1.7B | $3.4B | 10-K 2026-02-24 |
| Q3 2025 2025-09-30 | $672.4M | $24.5M | $161.1M | $80.4M | $1.8B | $3.0B | 10-Q 2026-11-03 |
| Q2 2025 2025-06-30 | $657.1M | $14.7M | $162.0M | $68.6M | $1.8B | $3.1B | 10-Q 2026-08-04 |
| Q1 2025 2025-03-31 | $777.9M | -$7.2M | $95.5M | $53.6M | $2.0B | $3.2B | 10-Q 2026-05-05 |
| Q4 2024 2024-12-31 | $856.6M | $50.3M | $150.4M | $109.7M | $2.0B | $3.3B | 10-K 2026-02-24 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2021-06-29 |
| Latest annual report | 10-K | 2026-02-24 |
| Latest quarterly / interim | 10-Q | 2026-11-03 |
| Latest current report | 8-K | 2026-11-03 |
| Latest proxy | DEF 14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 741 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +4.5% |
| 1 month | +21.0% |
| 3 months | +34.4% |
| Year to date | -23.1% |
| 1 year | -17.9% |
| From 52-week high | -42.8% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Nursing Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| OMDA | Omada Health Inc. | $14.49 | +1.12% | $898.9M |
| PNTG | The Pennant Group Inc. Common Stock | $37.03 | +2.66% | $1.3B |
| INNV | InnovAge Holding Corp. | $9.58 | +1.16% | $1.3B |
| USPH | U.S. Physical Therapy Inc. | $99.55 | +0.41% | $1.5B |
| WGS | GeneDx Holdings Corp. | $51.02 | -2.58% | $1.5B |
| TDOC | Teladoc Health Inc. | $8.70 | -1.14% | $1.6B |
| SBC | SBC Medical Group Holdings Incorporated | $6.18 | -15.92% | $635.6M |
| SRTA | Strata Critical Medical Inc. | $5.42 | -1.63% | $484.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier